Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Institut De Recherche International Servier |
---|---|
Information provided by: | Servier |
ClinicalTrials.gov Identifier: | NCT00202579 |
To evaluate the effects on heart function of ivabradine administered to patients with severe chronic heart failure
Condition | Intervention | Phase |
---|---|---|
Heart Failure, Congestive |
Drug: Ivabradine |
Phase II |
Study Type: | Interventional |
Study Design: | Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | Evaluation of the Effects on Peripheral and Central Haemodynamics Parameters, Safety, and Tolerance of Three-Hour Intravenous Perfusion (0.1 Mg/Kg) of Ivabradine Given to Severe Congestive Heart Failure Patients |
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Gaetano M De Ferrari, Dr | +39 03 82 503 972 |
Italy | |
Policlinico San Matteo | Recruiting |
Pavia, Italy, 27100 | |
Contact: Luigi Tavazzi, Pr + 39 03 82 503 157 |
Study Chair: | Luigi Tavazzi, Pr | Policlinico San Matteo |
Study ID Numbers: | CL2-16257-053 |
Study First Received: | September 12, 2005 |
Last Updated: | September 13, 2005 |
ClinicalTrials.gov Identifier: | NCT00202579 History of Changes |
Health Authority: | Italy: IRCCS Policlinico San Matteo di Pavia |
Heart Failure Heart Diseases |
Heart Failure Heart Diseases Cardiovascular Diseases |